… 随着精准治疗理念的发展,针对肿瘤细胞上特定靶点的靶向治疗得到了极大的发展,尤其在非小
细胞肺癌(Non-Small Cell Lung Cancer; NSCLC)中针对表皮生长因子受体(Epidermal Growth …

… for the treatment of non-small-cell lung cancer. Thereforeꎬthe … novel biomarkers of
immunotherapy in non-small cell lung … become a new target for clinical intervention and treatment …

… -target effect. CAR-T combination therapy offers new directions for improving cancer treatment
… HER2 status in non-small cell lung cancer: results from patient screening for enrollment to …

… in the acidic environment of the cell lysosome was achieved. … in vivo tracking of non-small-cell
lung cancer lesions through … of cancerous cells for early diagnosis of target cancers[60]. …

… , and may become the therapeutic target and predictive index. Target drugs for telomere
and … 肺癌分为小细胞肺癌（small cell lung cancer, SCLC）和非小细胞肺癌（non-small cell lung …

… that are found in the environment. Chemoprevention refers to the … KLT is a new biphase
extended-spectrum anticancer … in treating patients with stage IV of non-small-cell lung cancer or …

… Our results provide an insight regarding ECs in inflammation related cancer, and suggest
OSM pathway as a novel target for prevention and treatment of early-onset and metastasis of …

… drugs as anti-metastatic therapeutics. Overall, connexins may serve as biomarkers for
cancer prognosis and as therapeutic targets for intervening metastasis and chemoresistance. …

… TMB was significant in non-small cell lung cancer treated by PD-1… 1.4 文献质量评价 采用New
castle-Ottawa Scale(NOS)质量评 估量… Mutational landscape determines sensitivity to PD-1 …

… of lung cancer: small cell lung cancer (SCLC) and non-small … a novel target for drug
development to block uncontrolled … in lung cancer cells enables us to discover alternative target for …